The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
5 - Does a poster (developed by Canadian pharma company) intended to be used at an international conference need PAAB approval?
FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1
Posts
1
Posters
712
Views
1
Watching
-
Yes, if it originates in Canada and is controlled by the Canadian pharmaceutical company, it is subject to the PAAB Code. You can also see requirements for promotion/information at international meetings in the Health Canada guideline "The Distinction Between Advertising and Other Activities" that is available on the Health Canada web-site.
